The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 8
- 8 new
- Median first-year cost
- $708,092
- $10,374,594 in all
- Institutions
- 8
- 8 contact PIs
- Patents
- 1
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- BOSTON UNIVERSITY MEDICAL CAMPUS1
- BUCK INSTITUTE FOR RESEARCH ON AGING1
- DUKE UNIVERSITY1
- SCRIPPS RESEARCH INSTITUTE, THE1
and 3 other institutions
Most frequent study sections
- Special Emphasis Panel (ZAG1 ZIJ-U (A2))7
- ZAG1-ZIJ-U(A2)1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2018 | Identification of a missing key element underlying apoE2 neuroprotection in Alzheimer's disease and the aging brain1RF1AG061872-01 | Han, XianlinSeshadri, Sudha | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | First-year cost $3,382,940 | Study section ZAG1 |
| FY2018 | ApoE2 in Alzheimer's disease: the neuroprotective effects and mechanisms1RF1AG061794-01 | Shi, Yanhong | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | First-year cost $3,134,935 | Study section ZAG1 |
| FY2018 | Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells1R01AG061879-01 | Ellerby, Lisa MMelov, Simon | BUCK INSTITUTE FOR RESEARCH ON AGING, CA | First-year cost $879,592 | Study section ZAG1 |
| FY2018 | ApoE2 and protective molecular signatures in Alzheimer's disease and aging1R01AG061853-01 | Kulminski, Alexander M | DUKE UNIVERSITY, NC | First-year cost $781,190 | Study section ZAG1 |
| FY2018 | APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE21R01AG057565-01A1 | Koldamova, RadosvetaLefterov, Iliya | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $634,993 | Study section ZAG1 |
| FY2018 | Sleep and ApoE2 Interactions in Alzheimer Disease1R56AG061867-01 | Veasey, Sigrid C | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $594,698 | Study section ZAG1 |
| FY2018 | Neuroprotective Mechanisms of S-Nitrosylated ApoE2 in Aging and Alzheimer's Disease1R01AG061845-01 | Nakamura, Tomohiro | SCRIPPS RESEARCH INSTITUTE, THE, CA | First-year cost $483,750 | Study section ZAG1 |
| FY2018 | Protein Signatures of APOE2 and Cognitive Aging1R01AG061844-01 | Perls, Thomas TSebastiani, Paola | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | First-year cost $482,496 | Study section ZAG1 |
Patents from its funded projects
1 patent names 1 of the 8 funded projects.
- US 12,502,562 (opens the patent at USPTO, a PDF, in a new tab)HUMAN iPSC-DERIVED BRAIN ORGANOIDS AND USES THEREOFGranted December 23, 2025 to CITY OF HOPERF1AG061794 · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.